To establish a proof of concept and confirm if the FTO repression is response for GDM-mediated offspring cardiac hypertrophy, neonatal offspring aged 1–3 days from CTRL and GDM-exposed groups were used to isolate neonatal primary cardiomyocytes (NRCMs). The gene discussed is FTO; the disease is gestational diabetes.